A recent study illustrates that, after radiotherapy, tumor cells release large amounts of IL-1a to differentiate cancer-associated fibroblasts into inflammatory tumor-associated fibroblasts and cause oxidative-damage-mediated cellular senescence, leading to reduced radiotherapy sensitivity and tumor growth [176]. Here, IL1A is linked to neoplasm.